Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Conor Terrance Ronayne, Ph.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Schumacher TJ, Gardner ZS, Palle H, Mani C, Rumbley J, Mereddy VR. Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents. Bioorg Med Chem Lett. 2021 11 15; 52:128411. PMID: 34626786.
    Citations:    Fields:    Translation:HumansAnimalsCells
  2. Bennett CF, Ronayne CT, Puigserver P. Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease. FEBS J. 2022 11; 289(22):6969-6993. PMID: 34510753; PMCID: PMC8917243.
    Citations: 1     Fields:    
  3. Ronayne CT, Jonnalagadda SK, Jonnalagadda S, Nelson GL, Solano LN, Palle H, Mani C, Rumbley J, Holy J, Mereddy VR. Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53. Biochem Biophys Res Commun. 2021 07 12; 562:127-132. PMID: 34051576.
    Citations:    Fields:    Translation:AnimalsCells
  4. Gardner ZS, Schumacher TJ, Ronayne CT, Kumpati GP, Williams MJ, Yoshimura A, Palle H, Mani C, Rumbley J, Mereddy VR. Synthesis and biological evaluation of novel 2-alkoxycarbonylallylester phosphonium derivatives as potential anticancer agents. Bioorg Med Chem Lett. 2021 08 01; 45:128136. PMID: 34044122.
    Citations:    Fields:    Translation:HumansAnimalsCells
  5. Solano LN, Nelson GL, Ronayne CT, Jonnalagadda S, Jonnalagadda SK, Kottke K, Chitren R, Johnson JL, Pandey MK, Jonnalagadda SC, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Sci Rep. 2020 10 21; 10(1):17969. PMID: 33087745; PMCID: PMC7578069.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  6. Jonnalagadda SK, Wielenberg K, Ronayne CT, Jonnalagadda S, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents. Bioorg Med Chem Lett. 2020 07 15; 30(14):127259. PMID: 32527557.
    Citations:    Fields:    Translation:HumansAnimalsCells
  7. Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Rumbley J, Holy J, Rose-Hellekant T, Drewes LR, Mereddy VR. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment. Sci Rep. 2019 12 04; 9(1):18266. PMID: 31797891.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  8. Jonnalagadda S, Jonnalagadda SK, Ronayne CT, Nelson GL, Solano LN, Rumbley J, Holy J, Mereddy VR, Drewes LR. Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors. Oncotarget. 2019 Mar 22; 10(24):2355-2368. PMID: 31040927; PMCID: PMC6481325.
    Citations: 6     Fields:    
  9. Ronayne CT, Solano LN, Nelson GL, Lueth EA, Hubbard SL, Schumacher TJ, Gardner ZS, Jonnalagadda SK, Gurrapu S, Holy J, Mereddy VR. Synthesis and biological evaluation of 2-alkoxycarbonylallyl esters as potential anticancer agents. Bioorg Med Chem Lett. 2017 02 15; 27(4):776-780. PMID: 28129978.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  10. Gurrapu S, Jonnalagadda SK, Alam MA, Ronayne CT, Nelson GL, Solano LN, Lueth EA, Drewes LR, Mereddy VR. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents. Bioorg Med Chem Lett. 2016 07 15; 26(14):3282-3286. PMID: 27241692; PMCID: PMC5531278.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  11. Solano LN, Nelson GL, Ronayne CT, Lueth EA, Foxley MA, Jonnalagadda SK, Gurrapu S, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents. Bioorg Med Chem Lett. 2015 Dec 15; 25(24):5777-80. PMID: 26561365.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ronayne's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (55)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.